These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28159016)

  • 21. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
    Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
    Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis.
    Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P
    Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y
    Perera LMB; Sekiguchi A; Uchiyama A; Uehara A; Fujiwara C; Yamazaki S; Yokoyama Y; Ogino S; Torii R; Hosoi M; Ishikawa O; Motegi SI
    J Invest Dermatol; 2019 Apr; 139(4):890-899. PubMed ID: 30404019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
    Kavian N; Servettaz A; Mongaret C; Wang A; Nicco C; Chéreau C; Grange P; Vuiblet V; Birembaut P; Diebold MD; Weill B; Dupin N; Batteux F
    Arthritis Rheum; 2010 Nov; 62(11):3477-87. PubMed ID: 20583103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.
    Chora I; Romano E; Manetti M; Mazzotta C; Costa R; Machado V; Cortez A; Bruni C; Lepri G; Guiducci S; De Paulis A; Soares R; Matucci-Cerinic M
    J Rheumatol; 2017 Aug; 44(8):1190-1197. PubMed ID: 28507177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
    Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
    Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
    Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
    Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
    Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRB2 serves as a viable target against skin fibrosis in systemic sclerosis by regulating endothelial cell apoptosis.
    Huang Y; Zhao H; Shi X; Liu J; Lin JM; Ma Q; Jiang S; Pu W; Ma Y; Liu J; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2023 Sep; 111(3):109-119. PubMed ID: 37661474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.
    Lemaire R; Burwell T; Sun H; Delaney T; Bakken J; Cheng L; Rebelatto MC; Czapiga M; de-Mendez I; Coyle AJ; Herbst R; Lafyatis R; Connor J
    Arthritis Rheumatol; 2016 Feb; 68(2):473-83. PubMed ID: 26414805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
    Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
    Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.